{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:40:54Z","timestamp":1775216454630,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.phrs.2007.07.004","type":"journal-article","created":{"date-parts":[[2007,7,21]],"date-time":"2007-07-21T11:24:06Z","timestamp":1185017046000},"page":"267-274","source":"Crossref","is-referenced-by-count":23,"title":["Effects of celecoxib on voltage-gated calcium channel currents in rat pheochromocytoma (PC12) cells"],"prefix":"10.1016","volume":"56","author":[{"given":"Yuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunlin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phrs.2007.07.004_bib1","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.91.6.2046","article-title":"Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation","volume":"91","author":"Vane","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"10.1016\/j.phrs.2007.07.004_bib2","first-page":"4424","article-title":"Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells","volume":"56","author":"Subbaramaiah","year":"1996","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.phrs.2007.07.004_bib3","first-page":"447","article-title":"Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent","volume":"295","author":"Sun","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"10.1016\/j.phrs.2007.07.004_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/jjco\/hyi196","article-title":"Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis","volume":"35","author":"Sun","year":"2005","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"10.1016\/j.phrs.2007.07.004_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0026-895X(24)23023-6","article-title":"COX-2-selective inhibitors: the new super aspirins","volume":"55","author":"DeWitt","year":"1999","journal-title":"Mol Pharmacol"},{"issue":"9","key":"10.1016\/j.phrs.2007.07.004_bib6","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1172\/JCI119400","article-title":"Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2","volume":"99","author":"Sheng","year":"1997","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.phrs.2007.07.004_bib7","first-page":"69","article-title":"Cyclooxygenase-2 and carcinogenesis","volume":"1470","author":"Prescott","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"14","key":"10.1016\/j.phrs.2007.07.004_bib8","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1096\/fj.01-0299fje","article-title":"COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib","volume":"15","author":"Grosch","year":"2001","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.phrs.2007.07.004_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1471-4159.2001.00613.x","article-title":"Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord","volume":"79","author":"Tegeder","year":"2001","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.phrs.2007.07.004_bib10","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1158\/1078-0432.CCR-04-1877","article-title":"Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism","volume":"11","author":"Patel","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.phrs.2007.07.004_bib11","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1074\/jbc.275.15.11397","article-title":"The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2","volume":"275","author":"Hsu","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2007.07.004_bib12","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1124\/mol.105.020669","article-title":"Celecoxib inhibits interleukin-12 alphabeta and beta2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum","volume":"169","author":"Alloza","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.phrs.2007.07.004_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1023226616526","article-title":"The cox-2-specific inhibitor celecoxib inhibits adenylyl cyclase","volume":"27","author":"Saini","year":"2003","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/j.phrs.2007.07.004_bib14","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1158\/0008-5472.CAN-03-2396","article-title":"3-phosphoinositide-dependent protein kinase-1\/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells","volume":"64","author":"Kulp","year":"2004","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.phrs.2007.07.004_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-Kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.phrs.2007.07.004_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.cellbio.16.1.521","article-title":"Structure and regulation of voltage-gated Ca2+ channels","volume":"16","author":"Catterall","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.phrs.2007.07.004_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev.bi.64.070195.002425","article-title":"Structure and function of voltage-gated ion channels","volume":"64","author":"Catterall","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.phrs.2007.07.004_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000016320","article-title":"Pharmacology, structure and function of cardiac L-type Ca2+ channels","volume":"9","author":"Striessnig","year":"1999","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.phrs.2007.07.004_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-5793(94)80502-4","article-title":"Cardiac L-type Ca2+ channel triggers transmitter release in PC12 cells","volume":"342","author":"Avidor","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.phrs.2007.07.004_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn1632","article-title":"Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models","volume":"9","author":"Day","year":"2006","journal-title":"Nat Neurosci"},{"issue":"12","key":"10.1016\/j.phrs.2007.07.004_bib21","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1038\/sj.npp.1301123","article-title":"Expression of urocortin 2 and its inhibitory effects on intracellular Ca2+ via L-type voltage-gated calcium channels in rat pheochromocytoma (PC12) cells","volume":"31","author":"Tao","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2007.07.004_bib22","doi-asserted-by":"crossref","first-page":"44335","DOI":"10.1074\/jbc.M407023200","article-title":"Transcript scanning reveals novel and extensive splice variations in human l-type voltage-gated calcium channel, Cav1.2 alpha1 subunit","volume":"279","author":"Tang","year":"2004","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.phrs.2007.07.004_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.phrs.2004.05.006","article-title":"Effect of urocortin on L-type calcium currents in adult rat ventricular myocytes","volume":"50","author":"Tao","year":"2004","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.phrs.2007.07.004_bib24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3949\/ccjm.59.6.617","article-title":"Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance","volume":"59","author":"Triggle","year":"1992","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"10.1016\/j.phrs.2007.07.004_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00232-005-0781-4","article-title":"Ion channels and cancer","volume":"205","author":"Kunzelmann","year":"2005","journal-title":"J Mem Biol"},{"key":"10.1016\/j.phrs.2007.07.004_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1196\/annals.1294.014","article-title":"Ca2+ channel properties in neuroendocrine tumor cell cultures investigated by whole-cell patch-clamp technique","volume":"1014","author":"Mergler","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.phrs.2007.07.004_bib27","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.bcp.2003.11.004","article-title":"Effect of celecoxib on Ca2+ movement and cell proliferation in human osteoblasts","volume":"67","author":"Wang","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.phrs.2007.07.004_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tips.2004.01.009","article-title":"Herbal alkaloid tetrandrine: fron an ion channel blocker to inhibitor of tumor proliferation","volume":"25","author":"Wang","year":"2004","journal-title":"Trends Pharmacol Sci"},{"issue":"4\u20136","key":"10.1016\/j.phrs.2007.07.004_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/10799890500464704","article-title":"Effect of celecoxib on Ca2+ fluxes and proliferation in MDCK renal tubular cells","volume":"25","author":"Wang","year":"2005","journal-title":"J Recept Signal Transduct Res"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661807001314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661807001314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T21:17:20Z","timestamp":1737321440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661807001314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1043661807001314"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2007.07.004","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}